Verified· 2 sources

PharmaMar AG

Summary

About the company

The core activity of PharmaMar is the development and marketing of cancer drugs, particularly marine-derived oncology therapies. The company researches and develops innovative treatments for cancer patients and offers products such as Yondelis, Zepzelca and Aplidin.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered3

Oncologic medicines

Oncologic medicines with marine derivatives, including Yondelis®, Zepzelca® and Aplidin®; information for healthcare professionals as well as patient and product support.

Pharmacovigilance

Pharmacovigilance for reporting side effects and adverse events; reporting via form, e-mail or telephone as well as information on medicine safety.

Strategic partnerships and licensing

Strategic partnerships, licensing and acquisition for oncological projects; collaboration with local companies for development and marketing outside Europe.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

PharmaMar AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

PharmaMar AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

PharmaMar AG in comparison

Industry comparisons are coming soon

Similar companies